Clinical Trial Title Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Trial Status Open to Enrollment
Start Date 08/17/2010
Location randall-childrens-hospital-at-legacy-emanuel
Trial Type Pediatric Cancer (Oncology)
Specific Condition Acute Lymphoblastic Leukemia (ALL)
Description This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.
Eligibility Criteria Patients must be enrolled on AALL08B1 prior to enrollment on a COG ALL therapeutic study

A bone marrow examination is required, unless there is a medical contraindication to having the test performed

Newly diagnosed acute leukemia: >25% blast on a BM aspirate (OR by pathologic diagnosis of acute leukemia on a bone marrow biopsy, OR a complete blood count documenting the presence of at least 1,000/uL circulating leukemic blasts)

Age: <31 years of age at diagnosis of acute leukemia
IRB Number
Principal Investigator Janice Olson, MD
Contact Name Children's Cancer and Blood Disorders Program
Contact Phone (503) 276-9300
Contact Fax
Contact E-Mail